Lambs infected with UV-attenuated sporocysts of Sarcocystis ovicanis produced abnormal sarcocysts and induced protective immunity against a challenge infection.
The present study surveyed the prevalence of natural infection of the sheep esophagus muscle with sarcocysts of Sarcocystis ovicanis and examined induction of protective immunity using UV-attenuated sporocysts. The overall prevalence of natural infection of the sheep was 95%. Infectivity of the collected sarcocysts was confirmed by shedding of sporulated oocysts after feeding infected esophageal tissues to dogs. To induce protective immunity, lambs were immunized 3 times (once a week) with 1.5 x 10(4) sporocysts exposed to UV-light for 30 min (UV-30 group) or 60 (UV-60 group) min and then challenged with 1.5 x 10(4) normal sporocysts at the 3rd week post the 1st vaccination. These lambs showed high survival and less clinical signs of sarcocystosis than normal infected lambs. The attenuated sporocysts produced abnormal cysts; small in size and detached from the muscle fiber. These abnormalities were more obvious in UV-60 group than UV-30 group. Also, the IFN-gamma level and lymphocyte percentage were increased while the total leukocyte count was decreased in the UV-60 group compared with other groups. The high level of IFN-gamma may be an evidence for the induction of Th1 responses which may have protective effect against a challenge infection.
Abdel-Baki
Abdel-Azeem
AA
College of Science, King Saud University, Riyadh, Saudi Arabia. azema1@yahoo.com
Allam
Gamal
G
Sakran
Thabet
T
El-Malah
El-Mahy
el-M
D000818:Animals; D004285:Dogs; D004947:Esophagus / Q000469:parasitology; D005243:Feces / Q000469:parasitology; D007371:Interferon-gamma / Q000378:metabolism; D008214:Lymphocytes / Q000276:immunology; D033661:Oocysts / Q000276:immunology*; D010446:Peptide Fragments / Q000378:metabolism; D015995:Prevalence; D016052:Protozoan Vaccines / Q000276:immunology; D012522:Sarcocystis / Q000166:cytology / Q000276:immunology* / Q000528:radiation effects*; D012523:Sarcocystosis / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D012720:Severity of Illness Index; D012756:Sheep / Q000276:immunology / Q000469:parasitology; D012757:Sheep Diseases / Q000276:immunology / Q000517:prevention & control*; D016019:Survival Analysis; D014466:Ultraviolet Rays; D014613:Vaccines, Attenuated / Q000276:immunology
D010446:Peptide Fragments; D016052:Protozoan Vaccines; D014613:Vaccines, Attenuated; C069261:interferon gamma (1-39); D007371:Interferon-gamma